Identification of 5-hydroxytryptamine receptor gene polymorphisms modulating hyperprolactinaemia in antipsychotic drug-treated patients with schizophrenia
Open Access
- 22 September 2016
- journal article
- research article
- Published by Taylor & Francis in The World Journal of Biological Psychiatry
- Vol. 18 (3) , 239-246
Abstract
Hyperprolactinaemia (HPRL) is a classical side effect of antipsychotic drugs primarily attributed to blockade of dopamine D2 subtype receptors in the pituitary gland. Although dopamine is considered the primary factor inhibiting prolactin release, the activity of prolactin-producing lactotrophs is also regulated by the secretagogues thyrotrophin releasing hormone, vasoactive intestinal polypeptide and serotonin (5-hydroxytryptamine; 5-HT). We describe the association between HPRL and a set of 29 SNPs from 5-HT receptor genes HTR1A, HTR1B, HTR2A, HTR2C, HTR3A, HTR3B and HTR6 in a population of 446 Caucasians (221 males/225 females) with a clinical diagnosis of schizophrenia (according to ICD-10: F20) who were treated with classical and/or atypical antipsychotic drugs. None of the studied autosomal markers were found to be associated with HPRL. However, a significant association was established between various HTR2C polymorphisms and HPRL. This study revealed an association between HPRL and X-chromosome haplotypes comprised of the rs569959 and rs17326429 polymorphisms.Keywords
This publication has 38 references indexed in Scilit:
- Antipsychotic treatment of schizophrenia: An updateAsian Journal of Psychiatry, 2014
- Psychotropic-Induced Hyperprolactinemia: A Clinical ReviewPsychosomatics, 2014
- Serotonin 5-HT1A Receptors as Targets for Agents to Treat Psychiatric Disorders: Rationale and Current Status of ResearchCNS Drugs, 2013
- Endophenotypes and serotonergic polymorphisms associated with treatment response in obsessive-compulsive disorderClinics, 2012
- Antipsychotic Dose Equivalents and Dose-Years: A Standardized Method for Comparing Exposure to Different DrugsBiological Psychiatry, 2010
- Current status of inverse agonism at serotonin2A (5-HT2A) and 5-HT2C receptorsPharmacology & Therapeutics, 2009
- Association of the promoter polymorphism −1438G/A of the 5-HT2A receptor gene with behavioral impulsiveness and serotonin function in women with bulimia nervosaAmerican Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 2005
- Direct Action of Serotonin on Prolactin, Growth Hormone, Corticotropin and Luteinizing Hormone Release in Cocultures of Anterior and Posterior Pituitary Lobes: Autocrine and/or Paracrine Action of Vasoactive Intestinal PeptideNeuroendocrinology, 1998
- Role of Vasoactive Intestinal Peptide and 5-HT2 Receptor Subtype in Serotonin Stimulation of Basal and Thyrotropin-Releasing-Hormone- Induced Prolactin Release in vitro from Rat Pituitary CellsNeuroendocrinology, 1998
- Effect of serotonin on basal and TRH-induced release of prolactin from rat pituitary glands in vitroEuropean Journal of Endocrinology, 1987